Skip to main content
Log in

In vivo metabolism of 2-[1′-phenyl-3′-(3-chlorophenyl)-2′-propenylyden]hydraz ino-3-methyl-4(3H)-quinazolinone in rats

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

The aim of this study was to investigate by HPLC the in vivo metabolism of 2-[1′-phenyl-3′-(3-chlorophenyl)-2′-propenylyden]hydrazino-3-methyl-4(3H)-quinazolinone as a substrate, and as a model compound in rats. The substrate was dissolved in DMSO/water (1∶4) and administered intraperitoneally at a dose of 100 mg/kg in a volume of approximately 0.1 mL. Blood samples were taken before and 30 min, 1.5, 3, 6, 9, 11, 30 and 48 h after i.p. drug administration. The chromatographic separation of the substrate and its metabolites was performed using a stainless steel Novopak C18 column (150 × 4.6 mm i.d., 5-μm particle size). The optimal composition of the mobile phase was reached by introducing different mixtures of pure acetonitrile and water in a linear gradient system. Following the biotransformation of this compound, 2-hydrazino-3-methyl-4(3H)-quinazolinone (M1) and 3-(3-chlorophenyl)-1-phenylprop-2-en-1-one (M2) derivatives were identified together with substrate by comparing them to reference standards using HPLC-UV/DAD. In addition, the composition of these metabolites and substrate was confirmed by LC-MS in plasma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Loncle C, Brunei JM, Vidal N, Dherbomez M, Letourneux Y (2004): Synthesis and antifungal activity of cholesterol-hydrazone derivatives. Eur J Med Chem 39:1067–1071.

    Article  CAS  PubMed  Google Scholar 

  2. Papakonstantinou-Garoufalias S, Pouli N, Marakos P, Chytyroglou-Ladas A (2002): Synthesis, antimicrobial and antifungal activity of some new 3-substituted derivatives of 4-(2,4-dichlorophenyl)-5-adamantyl-1H-1,2,4-triazole. Farmaco 57:973–977.

    Article  CAS  PubMed  Google Scholar 

  3. Rollas S, Gulerman N, Erdeniz H (2002): Synthesis and antimicrobial activity of some new hy drazones of 4-fluorobenzoic acid hydrazide and 3-acetyl-2,5-disubstituted-1,3,4-oxadiazolines. Farmaco 57:171–174.

    Article  CAS  PubMed  Google Scholar 

  4. Cocco MT, Congiu C, Onnis V, Pusceddu MC, Schivo ML, Logu A(1999): Synthesis and antimycobacterial activity of some isonicotinoylhydrazones. Eur J Med Chem 34:1071–1076.

    Article  CAS  Google Scholar 

  5. Karali N, Kocabalkanli A, Gürsoy A, Ateş Ö (2002): Synthesis and antitubercular activity of 4-(3-coumarinyl)-3-cyclohexyI-4-thiazolin-2-one benzylidenehydrazones. Farmaco 57:589–593.

    Article  CAS  PubMed  Google Scholar 

  6. Vicini P, Zani F, Cozzini P, Doytchinova I (2002): Hydrazones of 1,2-benzisothiazolehydrazides: synthesis, antimicrobial activity and QSAR investigations. Eur J Med Chem 37:553–564.

    Article  CAS  PubMed  Google Scholar 

  7. Popp FD (1989): Potential anticonvulsants. XII. Anticonvulsant activity of some aldehyde derivatives. Eur J Med Chem 24:313–315.

    Article  Google Scholar 

  8. Sridhar SK, Pandeya SN, Stables JP, Atmakuru R (2002): Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives. Eur J Pharm Sci 16:129–132.

    Article  CAS  PubMed  Google Scholar 

  9. Küçükgüzel SG, Mazi A, Sahin F, Öztürk S, Stables J (2003): Synthesis and biological activities of diflunisal hydrazide-hydrazones. Eur J Med Chem 38:1005–1013.

    Article  PubMed  Google Scholar 

  10. Todeschini AR, Miranda ALP, Silva KCM, Parrini SC, Barreiro EJ (1998): Synthesis and evaluation of analgesic, antiinflammatory and antiplatelet properties of new 2-pyridylarylhydrazone derivatives. Eur J Med Chem 33:189–199.

    Article  CAS  Google Scholar 

  11. Gaston MA, Dias LRS, Freitas ACC, Miranda ALP, Barreiro EJ (1996): Synthesis and analgesic properties of new 4-arylhydrazone 1-H pyrazole [3,4-b] pyridine derivatives. Pharm Acta Helv 71:213–219.

    Article  CAS  PubMed  Google Scholar 

  12. Yin HD, Hong M, Wang QB, Xue SC, Wang DQ (2005): Synthesis and structural characterization of diorganotin(IV) esters with pyruvic acid isonicotinyl hydrazone and pyruvic acid salicylhydrazone Schiff bases. J Organometal Chem 690:1669–1676.

    Article  CAS  Google Scholar 

  13. Rodriguez-Arguelles MC, Ferrari MB, Bisceglie F, Pelizzi C, Pelosi G, Pinelli S, et al. (2004): Synthesis, characterization and biological activity of Ni, Cu and Zn complexes of isatin hydrazones J Inorg Biochem 98:313–321.

    Article  CAS  Google Scholar 

  14. Terzioglu N, Gürsoy A (2003): Synthesis and anticancer evaluation of some new hydrazone derivatives of 2,6-dimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carbohydrazide. Eur J Med Chem 38:781–786.

    Article  CAS  PubMed  Google Scholar 

  15. Kaymakçioĝlu BK, Rollas S (2002): Synthesis, characterization and evaluation of antituberculosis activity of some hydrazones. Farmaco 57:595–599.

    Article  Google Scholar 

  16. Küçükgüzel ŞG, Rollas S, Küçükgüzel I, Kiraz M (1999): Synthesis and antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones. Eur J Med Chem 34:1093–1100.

    Article  Google Scholar 

  17. Patole J, Sandbhor U, Padhye S, Deobagkar DN, Anson CE, Powell A (2003): Structural chemistry and in vitro antitubercular activity of acetylpyridine benzoyl hydrazone and its copper complex against Mycobacterium smegmatis. Bioorg Med Chem Let. 13:51–55.

    Article  CAS  Google Scholar 

  18. Maccari R, Ottanà R, Vigorita MG (2005): In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides andcyanoboranes. Bioorg Med Chem Lett 15:2509–2513.

    Article  CAS  PubMed  Google Scholar 

  19. Buss JL, Ponka P (2003): Hydrolysis of pyridoxal isonicotinoyl hydrazone and its analogs. Biochim Biophys Acta 1619:177–186.

    CAS  PubMed  Google Scholar 

  20. Gulerman NN, Oruc EE, Kartal F, Rollas S (2000): In vivo metabolism of 4-fluorobenzoicacid [(5-nitro-2-furanyl)methylene]hydrazide in rats. Eur J Drug Metab Pharmacokinet 25:103–108.

    Article  CAS  PubMed  Google Scholar 

  21. Komurcu SG, Rollas S, Ulgen M, Gorrod JW, Cevikbas A (1995): Evaluation of some arylhydrazones of p-aminobenzoic acid hydrazide as antimicrobial agents and their in vitro hepatic microsomal metabolism. Boll Chim Farm 134:375–379.

    CAS  PubMed  Google Scholar 

  22. Yesilada A, Koyunoglu S, Saygih N, Kupeli E, Yesilada E, Bedir E, Khanc I (2004): Synthesis, anti-inflammatory and analgesic activity of some new 4(3H)-quinazolinone derivatives. Arch Pharm (Weinheim) 337:96–104.

    Article  CAS  Google Scholar 

  23. Kaymakcioglu BK, Rollas S, Kartal-Aricioglu F (2003): In vivo metabolism of N-phenyl-N′-(3,5-dirnethylpyrazole-4-yl) thiourea in rats. Eur J Drug Metab Pharmacokinet 28:273–278.

    CAS  PubMed  Google Scholar 

  24. Oruc EE, Kabasakal L, Rollas S (2003): The in vivo metabolism of 5-(4-nitrophenyl)-4-(2-phenylethyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione in rats. Eur J Drug Metab Pharmacokinet 28:113–118.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaymakçioĝlu, B.K., Aktan, Y., Süzen, S. et al. In vivo metabolism of 2-[1′-phenyl-3′-(3-chlorophenyl)-2′-propenylyden]hydraz ino-3-methyl-4(3H)-quinazolinone in rats. European Journal of Drug Metabolism and Pharmacokinetics 30, 255–260 (2005). https://doi.org/10.1007/BF03190629

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190629

Keywords

Navigation